A B S T R A C T An alternative fibrinolytic system, active at physiological pH, is present in peripheral blood leukocytes. The fibrinolytic proteases localized predominantly in the leukocyte granules are capable of degrading both fibrinogen and fibrin, and plasmin activity does not contribute significantly to this proteolytic event.
INTRODUCTION
Leukocytes are observed in intimate association with fibrin deposits in two fundamental biological processes. Within the confines of the vascular compartment, leukocytes frequently accumulate in complex thrombi consisting of fibrin and platelets (1) (2) (3) (4) (5) ; whereas in extravascular sites, the migration of leukocytes to sites of injury where fibrin has accumulated is a central feature of the inflammatory response (5) (6) (7) (8) (9) . In both circumstances, the interaction of these cells with fibrin may be active rather than passive, based on the morphologic identification of fibrin within leukocytes (5) (6) (7) (8) (9) , the accumulation of leukocytes in thrombi relative to their concentration in blood (4) , and the demonstration that fibrinolytic activity of leukocytes is not confined to low pH, at which many cathepsins are active, but also is observed at neutral pH (10) (11) (12) (13) (14) (15) (16) .
Although elements of the plasma fibrinolytic system,'
plasminogen and its proactivator, may be constituents of leukocytes (14, 17) , a number of studies have demonstrated within the cells a fibrinolytic system distinct from plasmin. This conclusion is based on the differential sensitivity of the systems to inhibitors, as well as comparisons of the molecular characteristics of the enzymes (11) (12) (13) (14) . The purpose of the present study is to examine the alternative fibrinolytic system of leukocytes with respect to: (a) the relative contribution of the plasminogen and the plasminogen-independent system to the total fibrinolytic activity of the leukocytes; (b) the molecular characteristics of cleavage of fibrinogen by leukocyte proteases; (c) the biologic properties of the fibrinogen cleavage fragments generated by leukocyte protease; and (d) the release of protease from leukocytes when subjected to appropriate stimulus.
'Fibrinolysis is defined in the generalized sense as the capacity to degrade either fibrinogen or fibrin substrates.
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METHODS
Leukocyte isolation and subcellular fractionation. Leukocytes were isolated from citrated whole blood according to previously described procedures (13) , with dextran (250,-000 mol wt) separation and brief hypotonic lysis to remove residual red cells. After three to five washes of the leukocytes in phosphate-buffered saline, pH 7.3 (PBS) ,' the leukocytes appeared morphologically intact by light microscopy and consisted of more than 80% granulocytes.8 More than 90% of the leukocytes in the starting blood sample were recovered. The washed cells were suspended at a concentration of approximately 108 cells/ml of PBS and lysed by repeated freezing and thawing (at least six cycles). The 3Lymphocytes, which constituted the remaining 15-20%o of the cells in such preparations, contain no detectable fibrinolytic activity (Plow, E. F., and T. S. Edgington. Unpublished observations).
presence of sodium dodecyl sulfate (SDS) as described by Weber and Osborn (19) . Under nonreducing conditions, 50 Ag fibrinogen or fibrinogen digests were applied to polymerized 5% acrylamide gels. For samples reduced with 2-mercaptoethanol, 100 jpg samples were applied to 7.5%o polyacrylamide gels. The gels were subjected to electrophoresis at 8 mA/gel and stained with Coomassie brilliant blue. Molecular weights of constituent chains of the various digests were estimated in the reduced system utilizing serum albumin (68,000), the heavy (50,000) and light chains (23,500) of IgG, ovalbumin (43,000), pepsin (35,000), trypsin (23, 300) , and myoglobulin (17, 200) as standards.
Release of leukocyte proteases. The release of LPf from leukocytes was assessed with zymosan preincubated with fresh plasma (20, 21 Proteins. The human fibrinogen utilized in this study was prepared by differential ethanol fractionation followed by ammonium sulfate precipitation (24, 25) . Such preparations have been routinely found to be more than 95% coagulable by thrombin and to be devoid of other proteins by immunoelectrophoresis, polyacrylamide gel electrophoresis in SDS, and protein electrophoresis in cellulose acetate. When TCA-precipitability of fibrin (A *A) was tested in an identical system, except that the sample was clotted with 10 U of thrombin before the addition of LPf. The clots were rimmed and removed by centrifugation, and the TCAprecipitability of the supernate was determined. Results are corrected for the TCA-precipitability of the radioactivity in the absence of LPf, which remained constant at 92% during the incubation. required for specific experiments, the fibrinogen was rendered plasminogen-free by incubation with lysine attached to Sepharose 2B beads (26) . Plasminogen was prepared according to the method of Deutsch and Mertz (27) 
RESULTS
The fibrinolytic capacity of leukocyte lysates, LPf, is clearly demonstrated by prolongation of the thrombin time of fibrinogen, as exemplified in Fig. 1 . LPt produced a progressive prolongation of the thrombin time of fibrinogen, and with the particular dilution of LPf utilized, the sample was uncoagulable after a 50-min incubation. The relative contribution of the plasminogen system to this fibrinolytic capacity of leukocytes was assessed by measuring the activity of LPf in the presence or absence of 0.2 M e-aminocaproic acid (EACA), an inhibitor of plasminogen activation and of plasmin. As shown in Fig. 1 , the prolonged thrombin time produced by LPf was not demonstrably altered by the presence of EACA. In contrast, the activity of purified plasmin was completely inhibited by this concentration of EACA. These results suggest that active plasmin did not contribute to the fibrinolytic activity of the leukocyte lysate.
The fibrinolytic activity of LPf is also demonstrable as an increase in the solubility of radioiodinated fibrinogen in TCA. As shown in Fig. 2 When leukocytes were fractionated into granular and cytoplasmic fractions, the fibrinolytic activity of LPf was predominantly associated with the granular fraction (Table II) . In all preparations, the activity of the granular fractions was significantly greater than the activity of the total lysate prepared from the same number of cells. This observation suggests that an inhibitor of LPf may be present in the leukocytes, and that this putative inhibitor is segregated from the LPf during subcellular fractionation. (30) . The fragment(s) in the 1-h LPf digest appeared larger than the X fragment, suggesting a mol wt of over 270,000, but unlike the X _-_ 7 fragment not coagulable by thrombin. After 6 h of en-_-_ 5 zymatic cleavage, only D and E fragments were identified in the plasmin digest; however, the LPf digest con-
tained a large fragment similar in size to the X frag- 
Anticoagulant properties of fibrinogen digests
The anticoagulant properties of the fragments generated by LPf and by plasmin are compared in Fig. 6 . LPf and plasmin digests of fibrinogen were withdrawn after varying periods of incubation, and the capacity of the digests to prolong the thrombin time of intact fibrinogen was assessed. In plasmin digests, it has been reported that maximum anticoagulant activity is associated with the Y fragment (34, 35) . In the particular plasmin digest utilized, the anticoagulant activity present in the 2-4-h samples corresponded to the appearance and disappearance of the Y fragment (see Fig. 4) ; whereas digests containing only the terminal fragments D and E (6 h) exhibited little anticoagulant activity. LPf digests also exhibited anticoagulant activity, but its time course and the extent of anticoagulant activity differed markedly from those of the plasmin digest. Anticoagulant activity of the LPf digests was recognized in the 4-h samples. This activity increased in the 6-h digest, persisted in the 24-h digest, and was not diminished by supplementation of the digest with additional LPf. Incubation of the LPf digests with thrombin before the addition of fibrinogen did not reduce thrombin activity. Also, when the thrombin concentration was increased from 1 to 10 U, producing a thrombin time of the control fibrinogen sample of less than 3 s, the mixture of the digests and fibrinogen was still uncoagulable. These observations suggest that the anticoagulant properties of the LPf digests may arise predominantly from interference with the polymerization of fibrin monomers rather than with interference with thrombin or the release of fibrinopeptides.
The interference of LPr digests with fibrin monomer polymerization is directly demonstrated in Fig. 7 . The polymerization reaction was observed spectrophotometrically in the presence or absence of selected LPf digests generated in Fig. 6 . Addition of the 6-h or 24-h digests to fibrin monomers significantly altered the polymerization reaction, affecting the initiation, the rate, and the final extent of polymerization. Such effects are consistent with a complexing of LPf-generated fragments with fibrin monomers that in turn produced defective and incomplete polymerization. Addition of the 1-h LPf digest, which exhibited minimal anticoagulant activity, to the fibrin monomers produced only minimal effects on polymerization. * Washed zymosan particles pretreated with plasma or PBS were suspended in 1.0 ml PBS containing 108 leukocytes. After a 1-h incubation at 37 C, the mixtures were centrifuged at 800 g for 10 min. The supernates were removed and tested directly for LPf activity. The pellets, containing the cells and zymosan, were resuspended in 1.0 ml PBS and subjected to six freeze-thaw cycles. The LPf activity released from the cells following freezing and thawing constituted the activity of the cells. sults with those observed in Fig. 6 suggests that the anticoagulant activity of LPf digests arise primarily if not entirely from inhibition of the polymerization phase of the fibrin transition.
Nonlytic release of fibrinolytic proteases from leukocytes
A number of studies have demonstrated that leukocytes actively secrete or release enzymes from granules when subjected to appropriate stimuli through a nonlytic mechanism (20, 21, 36, 37) . To evaluate specifically the release of LPf, zymosan particles activated by incubation with fresh plasma were utilized to stimulate leukocytes to undergo the release reaction (20, 21, 36, 37) . After incubation of the activated zymosan with 1 X 108 cells for 1 h, the mixture was centrifuged, and the supernatant medium was assayed for fibrinolytic activity. The supernatant medium from cells incubated with activated zymosan produced a characteristic prolongation of the thrombin time, and after 45 min the fibrinogen was uncoagulable (Fig. 8) . This activity was not inhibited by EACA, ruling out a contribution from plasmin. The supernate from control cells that had been incubated with nonactivated zymosan exhibited no fibrinolytic activity. The LPf activity of the supernate from stimulated cells represented approximately 50% of the fibrinolytic activity obtained by freezing and thawing the same number of cells (Table III) . Only 2% of the total lactic dehydrogenase activity, a cytoplasmic and nonreleasable enzyme (36, 37) , appeared in the supernatant medium from cells stimulated by activated zymosan, indicating that the cells had not been nonspecifically lysed by the stimulus. A similar percentage (4.2% of the lactic dehydrogenase activity) was detected in the supernatant medium from the control cells incubated with nonactivated zymosan. DISCUSSION Leukocytes are capable of proteolytic degradation of both fibrinogen and fibrin by an intrinsic enzymatic system distinct from plasmin. The failure of EACA to alter the fibrinolytic activity of LPf indicates that active plasmin was not present in the leukocyte lysates. This observation is consistent with the results of other studies (11) (12) (13) in which plasmin activity and the antigenic determinants of plasmin were not demonstrable in leukocytes. In contrast, Prokopowicz not only found evidence for the presence of the plasminogen system in leukocytes but also isolated plasminogen from leukocytes (14, 17) . Our observations do not resolve these apparent inconsistencies; but in preliminary observations, utilizing sensitive radioimmunochemical approaches (25, 29) , we have detected very low levels of plasmin-related antigens within several leukocyte preparations (nanogram levels per 10' cells). If the material in the leukocytes antigenically related to plasmin was entirely present as the inactive zymogen, plasminogen, or if an inhibitor of plasmin intrinsic to the leukocytes completely masked plasmin activity, plasmin would still not significantly contribute to the fibrinolytic activity of the cells.
The manner in which LPf cleaves fibrinogen is clearly distinct from plasmin. The high molecular weight fragments generated by LPf in early digests (up to 6 h) exhibit electrophoretic patterns similar to fibrinogen but are of lower molecular weight than the parent molecule. These fragments exhibit lower mobilities in SDS polyacrylamide gels under nonreducing conditions than the X fragment generated by plasmin, suggesting an apparent molecular weight of greater than 270,000 (28) . The observation that these high molecular weight fragments are not clotted by thrombin, in contrast to the X fragment, suggests that cleavage by LPf is not confined to the COOH-terminal aspects of the Aa and BP chains of fibrinogen, sites of early plasmin cleavage (30, 32 (12, 39) . The ability of the leukocyte proteases to cleave the gamma chain of fibrinogen rapidly distinguishes this system not only from plasmin but also from trypsin, thrombin, and a number of bacterial proteases (40, 41) . Because of this unusual specificity, the fibrinolytic leukocyte proteases may provide a unique probe for structural studies of the fibrinogen molecule.
Although the subject of relatively limited study, it is attractive to consider that the alternative fibrinolytic system may be of physiological significance (5, 9) . Activation of the coagulation system leads to release of fibrinopeptides A and B and the formation of fibrin. Leukocytes are subject to chemotaxis by fibrinopeptide B (4) and, once localized, they may be induced to release LPf by various mechanisms, including phagocytic or nonphagocytic reactions (36) . Release may also be evoked by immunologic effector systems including antigen: antibody complexes and complement activation (36) . The fibrinolytic and anticoagulant properties arising from this system suggest a significant role in physiological homeostasis of the coagulation system. Further investigation will be required to provide a broader and sounder perspective as to the significance of this system.
